Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating MT-8421 as monotherapy and in combination with nivolumab in selected advanced solid tumors has been terminated. The trial lists multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma
• Hepatocellular Carcinoma
• Melanoma
• Mesothelioma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Squamous Cell Carcinoma of the Head and Neck
• Urothelial Carcinoma

Drugs mentioned

• MT-8421
• nivolumab (nivolumab)

Snippet

Sponsor: Molecular Templates, Inc. | Conditions: Non Small Cell Lung Cancer, Hepatocellular Carcinoma | Phase 1 | Status: TERMINATED